2012
DOI: 10.1056/nejmoa1211585
|View full text |Cite
|
Sign up to set email alerts
|

Strategies for Multivessel Revascularization in Patients with Diabetes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

38
904
9
80

Year Published

2013
2013
2019
2019

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 1,654 publications
(1,066 citation statements)
references
References 21 publications
38
904
9
80
Order By: Relevance
“…Although, contemporary population data demonstrates evidence of reduction in cardiovascular complications with risk factor control in patients with diabetes 5, 6, it is not known whether this translates to improvements following coronary revascularization as recent randomized control trials continue to show worst outcomes in diabetic patients with complex coronary artery disease when treated with PCI compared with coronary artery bypass graft (CABG) 7, 8, 9.…”
Section: Introductionmentioning
confidence: 99%
“…Although, contemporary population data demonstrates evidence of reduction in cardiovascular complications with risk factor control in patients with diabetes 5, 6, it is not known whether this translates to improvements following coronary revascularization as recent randomized control trials continue to show worst outcomes in diabetic patients with complex coronary artery disease when treated with PCI compared with coronary artery bypass graft (CABG) 7, 8, 9.…”
Section: Introductionmentioning
confidence: 99%
“…Hasil ini serupa dengan penelitian-penelitian yang lainnya. 5,7,9,10 Hal tersebut terkait usia yang merupakan salah satu faktor risiko terjadinya PJK.Semakin bertambah usia, maka semakin besar risiko mengalami PJK. Namun, pada penelitian ini tidak dilakukan analisis pengaruh usia terhadap kesintasan disebabkan sebaran data yang tidak merata.…”
Section: Karakteristikunclassified
“…While advances in PTCA like DES reduce some of these side effects so much so that in many patients with 1-or 2-vessel disease there may be hardly any difference between the two approaches, but for multivessel CAD, the difference may become crucial. In this subgroup, CABG is not only associated with fewer recurrent events or need for re-intervention but also better survival and thus studies after studies consistently demonstrated the superiority of CABG over PTCA, use of DES notwithstanding [4,5]. Similarly, in other situations of profoundly virulent atherosclerosis, CABG may be the best option.…”
Section: Effect Of Diabetes Mellitusmentioning
confidence: 99%